The acquisition combines Covalon’s rich technology portfolio with AquaGuard’s excellent products and specialized salesforce, who will provide selling capabilities for and access to, the United States healthcare market; the largest healthcare market in the world.
Covalon researches, develops and commercializes new healthcare technologies that help save lives around the world. AquaGuard is a medical technology business that specializes in infection protection products that protect surgical incisions, IV sites, catheters, PICC lines, and other dressings from water and other moisture while a patient showers.
Future opportunities for Covalon lie in additional medical device technology companies; providing bolt-on opportunities in the infection control and management, surgical, vascular access and wound care markets.
Buyers will continue to look for scalable prospects rich in intellectual property, profitable distribution channels and massive total addressable markets (TAMs).
Opportunities will also arise as buyers continue to look at scaling their existing platforms, technology, IP, distribution channels and call points, with scalable, profitable and accretive acquisitions.
Advanced medical device technology companies are a target rich environment that can provide plenty of M&A opportunities on both the buy and sell side.
Total deal value of $12.4 million.
Potential for contingent consideration of up to $0.9 million.
Fiscal year-ended December 31, 2017 revenues of $8.5 million.
Implied total deal value to revenue of between 1.5x and 1.6x.
IMAP has closed 50 transactions in the Healthcare sector since 2015
IMAP Canada not only provides its clients with access to a greater universe of targets across the globe, it consistently delivers battle-tested valuation advice and deal-making expertise.
With its considerable experience in advising Advanced Medical Devices Companies, IMAP Canada ensured the acquisition process was smooth and the outcome successful.
With its expertise in recognizing opportunities in new markets, IMAP continues to invest in relationships with potential targets and buyers.